nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alleviation effects of epigallocatechin-3-gallate against acute kidney injury following severe burns
|
Xu, Hongyan |
|
|
28 |
2 |
p. 136-143 |
artikel |
2 |
Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022
|
Yanagita, Motoko |
|
|
28 |
2 |
p. 85-122 |
artikel |
3 |
Correction to: Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022
|
Yanagita, Motoko |
|
|
28 |
2 |
p. 123-124 |
artikel |
4 |
Correction to: Efficacy and safety of entecavir for hepatitis B virus-associated glomerulonephritis with renal insufficiency
|
Yu, Yani |
|
|
28 |
2 |
p. 179 |
artikel |
5 |
Development of pauci-immune necrotizing glomerulonephritis during pembrolizumab treatment
|
Matsumoto, Jun |
|
|
28 |
2 |
p. 177-178 |
artikel |
6 |
eGFR slope as a surrogate endpoint for end-stage kidney disease in patients with diabetes and eGFR > 30 mL/min/1.73 m2 in the J-DREAMS cohort
|
Sugawara, Yuka |
|
|
28 |
2 |
p. 144-152 |
artikel |
7 |
Potential influence of dietary guidance for advanced chronic kidney disease: comment on “Prevalence of hyponatremia and associated factors in patients with chronic kidney disease: the Fukuoka Kidney Disease Registry (FKR) study”
|
Sumi, Hirofumi |
|
|
28 |
2 |
p. 175-176 |
artikel |
8 |
Survival benefit of living donor kidney transplantation in patients on hemodialysis
|
Goto, Shunsuke |
|
|
28 |
2 |
p. 165-174 |
artikel |
9 |
Tenapanor for peritoneal dialysis patients with hyperphosphatemia: a phase 3 trial
|
Nakayama, Masaaki |
|
|
28 |
2 |
p. 153-164 |
artikel |
10 |
The role of a novel mineralocorticoid receptor antagonist, finerenone, in chronic kidney disease: mechanisms and clinical advances
|
Chen, Xinping |
|
|
28 |
2 |
p. 125-135 |
artikel |